(Q85055770)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

14 February 2020

main subject

1 reference

D M Kofler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B B Gawlik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

T Elter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Gianella-Borradori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C-M Wendtner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Hallek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

7 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

841-844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21979878%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.286

14 February 2020

exact match

0 references

cites work

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021

APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021

Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021

Search on chromosome 17 centromere reveals TNFRSF13B as a susceptibility gene for intracranial aneurysm: a preliminary study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.286

7 January 2021